CG
SRRA

Cutler Group’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Cutler Group’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,087
Closed -$224K – 5862
2022
Q2 		$224K Buy
4,087
+3,172
+347% +$166K 0.02% 937
2022
Q1 		$29K Buy
+915
New +$26.3K ﹤0.01% 2748

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Cutler Group's SRRA Position: Q3 2022 in Review

Cutler Group sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 4,087 shares — an estimated $224K sold.

Cutler Group first reported a position in SRRA in Q1 2022 and held it in 2 quarters. The position peaked at $224K in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • Cutler Group reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Cutler Group sold 4,087 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $224K.
  • Cutler Group first reported a position in Sierra Oncology, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • Cutler Group's Sierra Oncology, Inc. Common Stock position peaked at $224K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Cutler Group's 13F filing for Q3 2022, filed 25 Oct 2022.